This suggests that not HPV infection itself, but p16INK4a overexpression, contributes to shaping of the tumor microenvironment and p16INK4a-status could stratify patients for separate immunotherapeutic approaches in vSCC. This evidence concerns the gene CDKN2A and neoplasm.